Section Arrow
IRMD.NASDAQ
- iRadimed Corp
Quotes are at least 15-min delayed:2025/01/21 05:29 EST
Last
 59.17
+0.81 (+1.39%)
Day High 
59.18 
Prev. Close
58.36 
1-M High
59.31 
Volume 
50.17K 
Bid
51.4
Ask
60
Day Low
56.36 
Open
58.93 
1-M Low
51.58 
Market Cap 
739.62M 
Currency USD 
P/E 39.97 
%Yield 0.76 
10-SMA 56.96 
20-SMA 55.55 
50-SMA 54.56 
52-W High 59.31 
52-W Low 40.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.46/2.15
Enterprise Value
741.24M
Balance Sheet
Book Value Per Share
6.58
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
65.56M
Operating Revenue Per Share
4.97
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed:2025/01/21 05:29 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.